Ramin Farzaneh-Far, Chief Medical Officer at Ra Pharmaceuticals, Inc. (RARX), sold 10,595 shares at $33.29 ($351K) on 2019-07-15, disclosed to the SEC on 2019-07-16.
Open-market sale of $351k RARX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.97 | 6,379 | $210K | 60.0% |
| 2 | $33.29 | 4,216 | $140K | 40.0% |
| Total | $33.10 avg | 10,595 | $351K | 100% |
| Filing → |
| RARX | SELL | 2020-01-16 | $995K | — | Filing → |
| RARX | SELL | 2019-12-18 | $1.0M | — | Filing → |
| RARX | SELL | 2019-12-18 | $500K | — | Filing → |